Clinical Trials Start for Taiwan-Made Drug to Treat COVID-19

Reporter/Provider - Philip Brossard and Rick Yi

class="meta mb-0">Publish Date - 2022-04-21T12:43:36Z0 views

A Taiwan pharma company has started phase-3 trials for a drug to treat COVID-19. The recent spike in cases has given the company the sample size it needs to find out if the medicine works.

We value your privacy.

We use cookies to analyze the traffic of TaiwanPlus to improve our service. Click here to find out more about TaiwanPlus's privacy policy.

Learn more Got it

Like what you see?

Download TaiwanPlus App now!

Download